Home Newsfeeds JP Morgan Maintains Overweight on Synovus Finl, Lowers Price Target to $46

JP Morgan Maintains Overweight on Synovus Finl, Lowers Price Target to $46

JP Morgan analyst Steven Alexopoulos maintains Synovus Finl (NYSE:SNV) with a Overweight and lowers the price target from $60 to $46.

byBenzinga Newsdesk

July 1, 2022

1 minute read

JP Morgan analyst Steven Alexopoulos maintains Synovus Finl (NYSE:SNV) with a Overweight and lowers the price target from $60 to $46.

Why E-Commerce Marketplace Groupon’s Shares Are Surging Today

By Lekha Gupta

October 13, 12:54 PM

Roth MKM analyst Sean McGowan initiated coverage on Groupon Inc (NASDAQ: GRPN) with a

GRPN

Tether Now Top 22 Global Buyer Of US Treasury Bills, Surpasses Countries Like UAE, Australia

By Murtuza Merchant

September 5, 4:29 PM

Paolo Ardoino, the Chief Technical Officer of Tether (CRYPTO: USDT), on Tuesday, said that the company now holds an exposure of $72.5 billion in U.S. Treasury bills.

$USDT

Bristol-Myers Squibb, Toast And A Major REIT Stock: CNBC’s ‘Final Trades’

By Priya Nigam

August 11, 9:07 AM

On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Bristol-Myers Squibb Company (NYSE: BMY), which announced $4 billion aggregate accelerated

BMY

10 Short Squeeze Candidates: Getty Images, Genius Brands, Lannett And More

By Chris Katje

February 27, 11:35 AM

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.

BEEM

JP Morgan Maintains Overweight on Synovus Finl, Lowers Price Target to $46

Related Posts

Why E-Commerce Marketplace Groupon’s Shares Are Surging Today

Tether Now Top 22 Global Buyer Of US Treasury Bills, Surpasses Countries Like UAE, Australia

Bristol-Myers Squibb, Toast And A Major REIT Stock: CNBC’s ‘Final Trades’

10 Short Squeeze Candidates: Getty Images, Genius Brands, Lannett And More